Proliferation-dependent changes in amino acid transport and glucose metabolism in glioma cell lines

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 9, 2004, Pages 1244-1256

  Sasajima, Toshio ^a,b   Miyagawa, Tadashi ^a,c   Oku, Takamitsu ^a,d   Gelovani, Juri G ^a,e   Finn, Ronald ^a   Blasberg, Ronald ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b AKITA UNIVERSITY HOSPITAL   (Japan)

^c CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF MIYAZAKI   (Japan)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

18F fluorodeoxyglucose; Gliomas; Non metabolized amino acid transport; Tumor proliferation

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; AMINO ACID; AMINO ACID TRANSPORTER; CARBON 14; CYCLOLEUCINE; FLUORODEOXYGLUCOSE F 18; PENTETATE TECHNETIUM TC 99M; THYMIDINE; TRITIUM;

AMINO ACID TRANSPORT; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL DENSITY; CELL LEVEL; CELL MEMBRANE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOMA; GLIOMA CELL; GLUCOSE METABOLISM; GROWTH CURVE; HUMAN; HUMAN CELL; IMAGING; MALIGNANT NEOPLASTIC DISEASE; PROGNOSIS; RADIATION DETECTOR;

AMINO ACID TRANSPORT SYSTEMS; AMINOISOBUTYRIC ACIDS; CARBON RADIOISOTOPES; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOPENTANES; FLUORODEOXYGLUCOSE F18; GLIOMA; GLUCOSE; HUMANS; METABOLIC CLEARANCE RATE; RADIOPHARMACEUTICALS;

EID: 4544254126     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1512-2     Document Type: Article

References (52)

1. 11C)-methionine in brain tumors studied with positron emission tomography. Acta Radiol 1987; 28:225-229.
2. Lilja A, Lundqvist H, Olsson Y, Spännare B, Gullberg P, Långström B. Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions. Acta Radiol 1989; 30:121-128.
3. 11C-methionine uptake in brain tumors measured by positron emission tomography. J Neurooncol 1996; 27:163-171.
4. 18F)fluorotyrosine. J Nucl Med 1991; 32:1338-1346.
5. 18F]- fluorophenylalanine [in Japanese]. Nippon Rinsho 1992; 50:1457-1460.
6. 18F]-fluorophenylalanine and PET. J Nucl Med 1995; 35:1232-1237.
7. Ogawa T, Miura S, Murakami M, Iida H, Hatazawa J, Inugami A, Kanno I, Yasui N, Sasajima T, Uemura K. Quantitative evaluation of neutral amino acid transport in cerebral gliomas using positron emission tomography and fluorine-18 fluorophenylalanine. Eur J Nucl Med 1996; 23:889-895.
8. Christensen HN. Role of animo acid transport and counter-transport in nutrition and metabolism. Phys Rev 1990; 70:43-77.
9. Miyagawa T, Oku T, Uehara H, Desai R, Beattie B, Tjuvajev J, Blasberg R. "Facilitated" amino acid transport is upregulated in brain tumors. J Cereb Blood Flow Metab 1998; 18:500-509.
10. 18F-FDG in a herpes simplex virus thymidine kinase/ganciclovir brain tumor model. J Nucl Med 2003; 44:1845-1854.
11. 11C]-L- methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. J Nucl Med 1997; 38:517-522.
12. Samnick S, Bader JB, Hellwig D, Moringlane JR, Alexander C, Romeike BFM, Feiden W, Kirsch CM. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up. J Clin Oncol 2002; 20:396-404.
13. 11C] L-methionine uptake in gliomas. Neurosurgery 1989; 25:720-728.
14. 11C-methionine in cerebral glioma patients studied with PET. Acta Neurochir (Wien) 1990; 104:8-12.
15. De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, Salmon I, Brotchi J, Goldman S. Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 2001; 95:746-750.
16. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, Shimosegawa E, Ito H, Hatazawa J, Okudera T, Uemura K, Yasui N, Mineura K. Cerebral glioma: evaluation with methionine PET. Radiology 1993; 186:45-53.
17. 18F-fluorophenylalanine and positron emission tomography. Surg Neurol 1989; 31:468-469.
18. Hatazawa J, Itoh H, Shimosegawa E, Kanno I, Murakami M, Miura S, Iida H, Okudera T, Inugami A, Ogawa T, Fujita H, Satoh Y, Nagata K, Hirata Y, Uemura K. Accumulation ofL-[2-(F-18)]fluorophenylalanine in peri-infarct area in a patient with acute cerebral infarction. Ann Nucl Med 1994; 8:213-217.
19. Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Uemura K. Indications for differential diagnosis of nontumor central nervous system diseases from tumors. A positron emission tomography study. J Neuroimag 1997; 7:8-15.
20. Warburg O. On the origin of cancer cells. Science 1956; 123:309-314.
21. Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Shishido F, Uemura K. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 1994; 73:2386-2394.
22. Di Chiro G, Brooks RA, Patronas NJ, Bairamian D, Kornblith PL, Smith BH, Mansi L, Barker J. Issues in the in vivo measurement of glucose metabolism of human central nervous system tumor. Ann Neurol 1984; 15(Suppl):S138-S146.
23. Herholz K, Pietrzyk U, Voges J, Schröder R, Halber M, Treuer H, Sturm V, Heiss WD. Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. J Neurosurg 1993; 79:853-858.
24. Altman SA, Randers L, Rao G. Comparison of try pan blue dye exclusion and fluorometric assays for mammalian cell viability determinations. Biotechnol Prog 1993; 9:671-674.
25. Winsor CP. The Gompertz curve as a growth curve. Proc Natl Acad Sci U S A 1932; 18:1-8.
26. 18F] fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27:235-238.
27. Merkel DE, McGuire WL. Ploidy, proliferative activity and prognosis. DNA flow cytometry of solid tumors. Cancer 1990; 65:1194-1205.
28. Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993; 34:414-419.
29. Guidotti GG, Borghetti AF, Gazzola GC. The regulation of amino acid transport in animal cells. Biochim Biophys Acta 1978; 515:329-366.
30. Shotwell MA, Kilberg MS, Oxender DL. The regulation of neutral amino acid transport in mammalian cells. Biochim Biophys Acta 1983; 737:267-284.
31. Wang H, Huang W, Sugawara M, Devoe LD, Leibach FH, Prasad PD, Ganapathy V. Cloning and functional expression of ATA1, a subtype of amino acid transporter A, from human placenta. Biochem Biophys Res Commun 2000; 273:1175-1179.
32. Sugawara M, Nakanishi T, Fei YJ, Martindale RG, Ganapathy ME, Leibach FH, Ganapathy V. Structure and function of ATA3, a new subtype of amino acid transport system A, primarily expressed in the liver and skeletal muscle. Biochim Biophys Acta 2000; 1509:7-13.
33. Hatanaka T, Huang W, Martindale RG, Ganapathy V. Differential influence of cAMP on the expression of the three subtypes (ATA1, ATA2, and ATA3) of the amino acid transport system A. FEBS Lett 2001; 505:317-320.
34. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 1998; 273:23629-23632.
35. Pineda M, Fernández E, Torrents D, Estévez R, López C, Camps M, Lloberas J, Zorzano A, Palacín M. Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem 1999; 274:19738-19744.
36. +-independent neutral amino acid transporter with broad substrate selectivity. J Biol Chem 1999; 274:19745-19751.
37. Campbell WA, Sah DE, Medina MM, Albina JE, Coleman WB, Thompson NL. TA1/LAT-1/CD98 light chain and system L activity, but not 4F2/CD98 heavy chain, respond to arginine availability in rat hepatic cells. Loss of response in tumor cells. J Biol Chem 2000; 275:5347-5354.
38. 3H]methyl]-L- methionine. J Nucl Med 2000; 41:1250-1255.
39. 123I]iodo-α-methyl-L-tyrosine transport and 4F2 antigen expression in human glioma cells. Nucl Med Biol 2001; 28:5-11.
40. Minn H, Clavo AC, Grénman R, Wahl RL. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose andL-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1995; 36:252-258.
41. Haberkorn U, Ziegler SI, Oberdorfer F, Trojan H, Haag D, Peschke P, Berger MR, Altmann A, van Kaick G. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl Med Biol 1994; 21:827-834.
42. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J Nucl Med 1996; 37:1042-1047.
43. Higashi T, Tamaki N, Torizuka T, Nakamoto Y, Sakahara H, Kimura T, Honda T, Inokuma T, Katsushima S, Ohshio G, Imamura M, Konishi J. FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors. J Nucl Med 1998; 39:1727-1735.
44. Waki A, Kato H, Yano R, Sadato N, Yokoyama A, Ishii Y, Yonekura Y, Fujibayashi Y. The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro. Nucl Med Biol 1998; 25:593-597.
45. Marom EM, Aloia TA, Moore MB, Kara M, Herndon JE 2nd, Harpole DH Jr, Goodman PC, Patz EF Jr. Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer. Lung Cancer 2001; 33:99-107.
46. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol 2002; 9:15-18.
47. Tian M, Zhang H, Nakasone Y, Mogi K, Endo K. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study. Eur J Nucl Med Mol Imaging 2004; 31:5-12.
48. 3H-2-deoxyglucose retention in murine tumor models. Nucl Med Biol 1996; 23:533Tian M, Zhang H, Nakasone Y, Mogi K, Endo K541.
49. Aloj L, Caraco C, Jagoda E, Eckelman WC, Neumann RD. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture. Cancer Res 1999; 59:4709-4714.
50. 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol 2002; 20:379-387.
51. 18F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 2002; 43:173-180.
52. Brown RS, Goodman TM, Zasadny KR, Greenson JK, Wahl RL. Expression of hexokinase II and Glut-1 in untreated human breast cancer. Nucl Med Biol 2002; 29:443-453.